No clinical advantage to either rhythm or rate control
CTSN findings are changing practice across the U.S.
Robust robotics, preeminence of repair, and a rosy percutaneous future
Cleveland Clinic-led trial is first large randomized study of the combo
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy